Carregant...
Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: First case report
The effectiveness of hepatitis C treatment has improved with the development of interferon (IFN), and it has drastically improved with the development of peg-interferon-α (PEG-IFN) in combination with ribavirin (RBV) and, more recently, with the addition of a protease inhibitor. Simeprevir, which is...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4299317/ https://ncbi.nlm.nih.gov/pubmed/25624738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i3.1009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|